P3.06-002 ATLANTIS Trial: Phase III Study of PM01183/Doxorubicin vs. CAV or Topotecan in SCLC after One Platinum-Containing Line: Topic: Clinical StudiesAnna F. Farago,Martin Forster,Luis Paz-Ares,Carmen Puparelli,Sergio Szyldergemajn,Jose Antonio Lopez-Vilariño, Keren Rachel Moss,Carmen Kahatt,Arturo Soto-Matos,Maria Eugenia OlmedoJournal of Thoracic Oncology（2017）引用 1|浏览19暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
